La cicatrisation parodontale est un processus complexe, composé de quatre phases hautement intégrées (hémostase, inflammation, prolifération, remodelage), qui nécessite une interaction complexe entre les différents types tissulaires (épithélium, conjonctif, os) ainsi que la synthèse de médiateurs, tels que les hormones et les facteurs de croissance. La difficulté à pouvoir obtenir une régénération des tissus parodontaux est en partie due à la réponse inflammatoire qui interfère avec le processus de cicatrisation, via la surexpression des cytokines pro-inflammatoires, ainsi qu’à la croissance rapide des cellules épithéliales le long de la surface de la racine qui porte atteinte à la vraie organisation des tissus, essentielle à la régénération parodontale. Notre objectif a été de mettre au point des membranes nanofibreuses implantables à base de polycaprolactone (PCL) fonctionnalisés par plusieurs molécules actives (Alpha-Melanocyte Stimulating Hormone (α-MSH)), ibuprofène, atorvastatine) et implantables, permettant à la fois un contrôle physique et biochimique de la cicatrisation parodontale. En d’autres termes, nous avons cherché à ralentir la colonisation de la surface radiculaire par les cellules épithéliales et à moduler l’inflammation de la phase post-chirurgicale afin de promouvoir la cicatrisation parodontale. Pour cela, nous avons mis au point un modèle d’inflammation in vitro mimant le tissu superficiel du parodonte en utilisant des cellules parodontales, à savoir des kératinocytes et fibroblastes gingivaux humains, stimulées par du lipopolysaccharide de Porphyromonas gingivalis (LPS-Pg). Les résultats obtenus ont montré une bonne biocompatibilité des systèmes (α-MSH, ibuprofène) ainsi qu’une diminution de la prolifération, migration des kératinocytes, fibroblastes gingivaux humains et une diminution significative de l’expression des marqueurs pro- ou anti-inflammatoires (TNF-α, TGF-β, IL-6, IL-8), des marqueurs d’adhérence, de prolifération (Intégrine, Laminine, Fibronectine) et de remodelage (COL-IV). En conclusion, les stratégies développées (α-MSH, ibuprofène) au sein de notre laboratoire ont permis de mettre en évidence l’intérêt de délivrer une molécule anti-inflammatoire à partir d’un biomatériau et représentent un fort potentiel d’application clinique pour la parodontologie mais aussi pour la médecine de demain. / Periodontal wound healing is a process involving hemostasis, inflammatory phase, proliferation and maturation/matrix remodeling. These phases require cell-to-cell interaction of different cell types (epithelial cells, fibroblasts, osteoblasts, and cementoblasts) orchestrated by growth factors, cytokines and extracellular matrix components. After conventional periodontal therapy, wound healing corresponds more to tissue reparation than regeneration. This absence of true regeneration is considered to be mainly due to the competition between the different periodontal tissues (gingiva, cementum, alveolar bone) and the differential rate of proliferation, migration and differentiation of periodontal cells during wound healing. Therefore, the inflammatory response could interfere with the healing process depending on the secretion/activity level of matrix metalloproteinase (MMPs), cytokines, chemokines and also the imbalance with their antagonists/inhibitors, which leads to fibrosis and excessive scarring. Our aim was to develop implantable nano-fibrous membranes based on polycaprolactone (PCL) and functionalized by several active molecules (Alpha-melanocyte stimulating hormone (α-MSH)), ibuprofen, atorvastatin) allowing both physical control and biochemical periodontal healing features. Furthermore, we developed an in vitro inflammatory model mimicking the periodontal tissue surface, using periodontal cells ; keratinocytes and human gingival fibroblasts stimulated with lipopolysaccharide of Porphyromonas gingivalis (Pg-LPS). The results obtained showed good biocompatibility systems (α-MSH, ibuprofen) and a decrease in the proliferation and migration of keratinocytes, human gingival fibroblasts. Moreover, a significant decrease of pro- or anti-inflammatory markers expression (TNF-α, TGF-β, IL-6, IL-8), adhesion markers of proliferation (Integrin, laminin, fibronectin) and remodeling (COL-IV) could be achieved. In conclusion, the strategies developed in our laboratory (α-MSH, ibuprofen), have helped to highlight the interest of the release of an anti-inflammatory molecule from a biomaterial, and represented a strong potential for clinical application not only in periodontics but also in general medicine.

Kidney failure is frequently associated with the risk factors linked to metabolic syndrome. Lipopolysaccharide (LPS) is a potent inflammatory molecule, which has increased absorption from the gut into blood circulation following a high fat and high-energy diet. We hypothesized that LPS from a high fat diet can amplify inflammation, thereby exacerbating chronic kidney disease and associated disorders. We have found that adding a high fat diet to renal insufficient mice significantly progressed their kidney disease as well as associated disorders, compared to both a high fat diet and renal insufficiency alone. Additionally, we were able to demonstrate in vitro that the combination of LPS and palmitic acid, a marker of high fat diet, induced inflammatory pathways significantly more than either LPS or palmitic acid alone. These results provide insight into connection between a high fat diet and the progression of chronic kidney disease as well as associated disorders.

Actinobacillus pleuropneumoniae est un bacille Gram-négatif de la famille des Pasteurellaceae. A. pleuropneumoniae est l'agent étiologique de la pleuropneumonie porcine, une maladie hautement contagieuse et endémique qui cause encore à ce jour d’énormes pertes économiques dans le monde de l’industrie porcine. La pathogenèsedes infections à A. pleuropneumoniae implique plusieurs facteurs de virulence de la bactérie dont les principaux sont les lipopolysaccharides (LPS) et la capsule polysaccharidique (CPS). Ces derniers sont impliqués dans l'adhérence d’A. pleuropneumoniae. Très récemment, il a été démontré qu’A. pleuropneumoniae était capable de produire, sous certaines conditions un biofilm riche en poly- N-acétyl-D-glucosamine (PGA). Cependant, le rôle de cette structure dans la pathogenèse ainsi que les facteurs intervenant dans sa formation et ses signaux déclencheurs sont peu connus à ce jour. Dans cette étude, nous avons démontré que l’antigène O du LPS joue un rôle important dans la formation d’un biofilm mature par A. pleuropneumoniae que ce soit dans un modèle statique ou dans un modèle dynamique en flux, le «drip flow reactor», plus représentatif de l’environnement pulmonaire. Alors que l’absence de la capsule ou du noyau oligosaccharidique du LPS ne semble pas affecter la formation du biofilm, le défaut de formation du biofilm chez le mutant antigène O semble être lié à un problème de production de PGA. En effet, des tests d’immunodétection du PGA associé aux bactéries, à l’aide d’anticorps spécifiques, et les études d’expression du PGA démontrent que le mutant antigène O produit moins de polysaccharide. De plus, les gènes codant pour le système de stress exocytoplasmique CpxRA semblent être moins exprimés chez le mutant antigène O. I L’expression du système CpxRA a également été étudiée lors de l’exposition de souches faiblement productrices de biofilm à des doses sous inhibitrices de pénicilline G (sous-CMI de PG). L’expression des gènes cpxR et cpxA ainsi que d’un gène codant pour la biosynthèse du PGA est augmentée après exposition à des doses sous-CMI de PG. Cette augmentation est suivie d’une augmentation de la capacité des souches étudiées à former un biofilm ainsi que d’une modification de la composition de la matrice extracellulaire. Ces résultats suggèrent que des doses sous-CMI de PG semblent agir comme signaux activateurs de la formation de biofilm chez A. pleuropneumoniae. Finalement, des expériences visant à établir l’implication du biofilm dans l’échappement d’A. pleuropneumoniae au système immunitaire ont démontré que les bactéries du biofilm sont moins susceptibles d’activer des cellules immunitaires que les bactéries planctoniques. À l’aide de la spectrométrie de masse, nous avons démontré une distribution différente des structures du lipide A du LPS entre les bactéries planctoniques et ceux du biofilm. Ces modifications structurelles au niveau du lipide A pourraient expliquer, du moins en partie, cette diminution de la réponse inflammatoire suite à l’exposition des macrophages aux bactéries du biofilm d’A. pleuropneumoniae. Au cours de ce projet, nous avons ainsi pu identifier de nouveaux facteurs importants pour la formation du biofilm d’A. pleuropneumoniae nous permettant de mieux comprendre les mécanismes de formation du biofilm ainsi que son implication dans la pathogénicité. / Actinobacillus pleuropneumoniae is a Gram-negative bacterium belonging to the Pasteurellaceae family and the causative agent of porcine pleuropneumonia, a highly contagious disease that causes important economic losses to the swine industry worldwide. Several virulence factors of A. pleuropneumoniae have been identified. These factors include the Apx toxins, iron uptake systems and surface polysaccharides. Surface polysaccharides including lipopolysaccharides (LPS) and capsular polysaccharides (CPS) are implicated in the adhesion of A. pleuropneumoniae. Recent literature indicates that A. pleuropneumoniae has the ability to rapidly form a biofilm rich in poly-N-acetyl-D-glucosamine (PGA). However, the role of the biofilm in the pathogenesis as well as factors and signals involved in are little known to date. In this study, we demonstrated that the LPS O antigen plays an important role in the biofilm formation by A. pleuropneumoniae whether in a static model or a dynamic model under continuous flow, the "drip flow reactor" which is more representative of the lung environment. While truncation of the LPS core oligosaccharide or the absence of CPS did not have any effect, absence of O antigen markedly reduced the ability of A. pleuropneumoniae serotype 1 to form a mature biofilm. This finding was linked for the O-antigen mutant to a reduced pgaA expression and, consequently, a reduced PGA production. Indeed, compared to the parental or other strains, the biofilm of the O-antigen mutant was dramatically reduced and it had less cell-associated PGA. Real-time PCR analyses revealed a significant reduction in the level of pgaA which encodes for biosynthesis of PGA. Interestingly, the O-antigen mutant also exhibited reduced expression of stress extracytoplasmic CpxRA system. Expression of CpxRA system was also investigated during the exposure of field isolates of A. pleuropneumoniae to sub-minimal inhibitory concentrations of penicillin G (sub-MICs of PG). III Surprisingly, cpxR, cpxA and pgaA expression was increased after exposure to sub-MICs of PG. The up-regulation of these genes was followed by an increase of the capacity of the studied strains to form a biofilm as well as a change in the composition of the induced biofilm extracellular matrix. These results suggest that sub-MICs of PG seem to act as activators signal towards biofilms of A. pleuropneumoniae. Finally, experiments to establish the involvement of the biofilm in the immune evasion of A. pleuropneumoniae have shown that biofilm cells have weaker ability to stimulate innate immune cells compared to planktonic bacteria. Using mass spectrometry, we demonstrated a different distribution of structures of lipid A of LPS between planktonic bacteria and those of the biofilm. These structural changes in the lipid A could explain, at least in part, the reduction of the inflammatory response following exposure of macrophages to A. pleuropneumoniae biofilm cells compared to their planktonic counterparts. During this project, we were able to identify new factors important for biofilm formation of A. pleuropneumoniae allowing us to better understand the biofilm formation and its involvement in pathogenicity.

A sílica mesoporosa SBA-15 é uma forte candidata para uso como adjuvante por apresentar propriedades vantajosas, como a capacidade de integração com moléculas, baixa toxicidade, boa estabilidade química, térmica e hidrotérmica. Seu potencial adjuvante foi demonstrado em trabalhos onde a SBA-15 associada a antígenos de naturezas distintas foi capaz de induzir uma alta produção de anticorpos específicos quando administrados por via parenteral. Além disso, a SBA-15 diminuiu a toxicidade da toxina diftérica na imunização de cavalos. Os efeitos da SBA-15 na produção de anticorpos com imunizações exclusivamente administradas pela via oral não havia sido testada. Assim, verificou-se a produção de anticorpos em camundongos heterogênicos selecionados para alta (HIII) e baixa (LIII) produção de anticorpos e em animais de fundo genético conhecido (BALB/c), após imunização oral com dois antígenos de naturezas distintas: LPS (antígeno T-independente) e flagelina (antígeno Tdependente), associados a sílica SBA-15. Os camundongos foram inoculados com duas doses de LPS ou flagelina de Salmonella typhimurium, associados ou não a SBA-15, pela via oral ou por via subcutânea. Foram pesquisados anticorpos séricos IgM, IgG e IgA, S-IgA no lavado intestinal e citocinas no soro. Células do linfonodo mesentérico foram coletadas após a imunização oral para caracterização fenotípica. Houve IgM anti-flagelina detectável em BALB/c no período de 37 dias no grupos Fla+SBA-15. Os animais de ambas as linhagens produziram IgG anti-LPS e anti-flagelina em todos os períodos avaliados. Foi encontrada uma pequena diferença significativa em BALB/c, entre os grupos Fla+SBA-15 e Fla após reforço por via oral. Não foi possível detectar IgA sérica nem secretória nos lavados intestinais. Não houve níveis detectáveis de citocinas nos soros do período avaliado. Foram encontrados linfócitos B1, T CD4+ e T CD8+, células dendríticas e moléculas coestimulatórias CD80 e CD86. Houve diferença estatística nas células dendríticas de HIII entre os grupos LPS+SBA-15 e LPS. / Ordered mesoporous sílica SBA-15 is a vaccine adjuvant candidate due to its advantageous properties such as the ability to associate with molecules, low toxicity, and also good chemical, thermal and hydrothermal stability. It has been demonstrated that the association of SBA-15 with several antigens, including toxins, induce high production of specific antibodies when injected parenterally.Since the oral route is natural for most infections, oral vaccination would be suitable for immunization against several diseases. Thus, we verified the antibody production of the non-isogenic mice selected for high (HIII) and low (LIII)antibody response after oral immunization with two antigens with distinct nature: LPS (T-independent antigen) and flagellin (Tdependent antigen), associated with silica SBA-15 Three mice per groupwere orally inoculated (gavage) with twodoses of LPS (75μg) or Salmonella typhimurium flagellin (50μg) adsorbed/encapsulated or not to SBA-15 at a 1:10 ratio on days 0 and 30. Blood sampleswere collectedon days 7 and 37andIgG serum levels were determined by ELISA.There was an increasing in antibody levels in HIII animalsi mmunized with both antigens associated with silica when compared to those immunized with antigen alone. We observed highest antibody levels in two of three HIII mice immunized with both antigens, although, due to the small sample, no significant differences were found between groups treated with silica or not. No significant difference was observed in LIII animals. The oral adjuvant effect of silica is encouraging by these preliminary results but must be confirmed by further experiments with a larger number of animals.

A depressão é hoje a doença mental mais comum do mundo, afetando mais de 121 milhões de pessoas. Além disso, estima-se que em aproximadamente uma década ela se torne a 2º doença responsável pela perda prematura de vida entre todas as idades e sexos. Diferentes propostas foram feitas no intuito de se compreender os mecanismos pelos quais essa doença incide, contudo a etiologia dos transtornos depressivos ainda não é totalmente entendida. Existem consideráveis evidências de que a administração perinatal de lipopolissacarídeo (LPS), uma endotoxina bacteriana, promove efeitos persistentes no desenvolvimento e comportamento da prole de camundongos, os quais podem-se manter até a idade adulta. Ainda, esses eventos podem ter implicações evolucionárias ligadas a alterações transgeracionais. Tendo em vista que a ativação do sistema imune pode estar relacionada com os transtornos depressivos, o presente trabalho expos pré-natalmente ao LPS uma geração de camundongos avaliando os efeitos comportamentais dessa exposição em três gerações subsequentes levando-se em consideração os comportamentos depressivos e não depressivos de cada geração avaliada. Para isso camundongos fêmeas, após terem o comportamento selecionado pelo teste de suspensão da cauda (TSC), foram cruzadas com machos de mesmo comportamento recebendo 100g/kg de LPS ou solução salina no 15º dia de prenhez. Após os nascimentos, as gerações subsequentes tiveram o comportamento em questão avaliado pelo TSC, bem como a atividade geral em campo aberto. Além disso, a interação materno-filhote foi avaliada, uma vez que alterações na mesma poderiam contribuir para os efeitos do tratamento com a endotoxina. Ainda, foi-se realizado um desafio com LPS na geração filial 3, na qual o nível de citocinas e a expressão do comportamento doentio foram avaliadas. Os resultados mostraram que (i) a administração do LPS na geração parental não afetou o comportamento depressivo e não depressivo nas três gerações avaliadas, dado que animais com comportamento depressivo tiveram mais filhotes com o mesmo comportamento em todas as gerações. (ii) Foram observadas alterações no comportamento materno da geração parental, possivelmente ligadas a motivação materna desses animais. (iii) Foram encontradas alterações transgeracionais na atividade geral de camundongos machos e fêmeas das gerações filiais 1 e 2. Tais alterações foram mais x expressivas nos machos e, havendo diferenças entre o comportamento. Esses dados apontam que a exposição a endotoxina possui diferentes consequências de acordo com o comportamento e, (iv) os animais da geração filial 3 quando desafiados com a endotoxina apresentaram maior comportamento doentio e maiores níveis de citocinas. Esses dados apontam para um forte componente genético na transmissão do comportamento, além de, uma influencia epigenética na modulação do mesmo. Ainda, foi possível concluir que a inflamação gerada pela administração pré-natal do LPS atua de forma distinta entre os sexos, bem como o histórico comportamental, no caso, o comportamento depressivo e não depressivo estudados nesse trabalho / Depression disorders are to be considered the most common mental illness affecting more than 121 million people worldwide. It is estimated that approximately one decade it becomes the 2nd disease most responsible for premature loss of life of all ages and sexes. Different proposals to understand this disorders have been made in the past years, however its etiology it is still yet fully understood. There is considerable evidence that the administration of lipopolysaccharide (LPS), a bacterial endotoxin, promotes persistent effects on development and behavior of the offspring of mice, which are maintained into adulthood. Still, these events may have evolutionary implications related to transgenerational changes. Given that activation of the immune system may be related to depressive disorders, this study aimed to expose a generation of mice to LPS evaluating the behavioral effects on three subsequent generations taking into account the depressive-like and non depressive-like behaviors assessed on each generation by the tail suspension test (TST). For this, female mice after behavior selected by the tail suspension test (TST) were crossed with males of the same behavior and exposed to 100g/kg of LPS or saline solution on day 15th of pregnancy. After births, the subsequent generations were also evaluated on the TST and in the open field for general activity. In addition, the maternal interaction was also evaluated, since changes on this parameter could contribute to the treatment effects of the endotoxin. Yet, has been performed a challenge with LPS in the generation branch 3, wherein the level of expression of cytokines and sickness behavior were evaluated. The results showed that (i) the administration of LPS in the parental generation did not affect the depressive-like behaviors on the three generations evaluated, since animals with depressive-like and non depressive-like behavior had more offspring with the same behavior in all generations. (ii) Changes were observed in maternal behavior of the parental generation which is possibly related to a change in motivational state of those animals. (iii) Transgenerational alterations were found in the general activity of male and female mice of the filial generation 1 and 2. These changes were more significant in males and differences between depressive-like e non depressive-like behaviors were also observed. Together, these data indicate that the exposure to endotoxin has different consequences according to the animal historical behavior and, xii finally, (iv) the animals of filial generation 3 when challenged with endotoxin had higher sickness behavior and higher levels of cytokines when evaluated in the open field test. These data point to a strong genetic component in the transmission of behavior and, besides, a possible influence of epigenetic mechanism of the same. Furthermore it was possible to concluded that inflammation state created by the prenatal LPS exposure acts differently according to the animal historical behavior, in this case, the depressive-like and non depressive-like behavior studied, and also acting differently according to the sexes

Linhagens de camundongos selecionadas para a máxima (AIRmax) ou mínima (AIRmin) resposta inflamatória aguda diferem tanto na susceptibilidade a infecção por Salmonella entérica sorotipo Typhimurium (S. Typhimurium) e ao LPS. Diferentes frequências dos alelos do gene Nramp1, envolvido na resistência inata a infecção por S. Typhimurium, foram encontradas nas linhagens AIRmax e AIRmin. Para o estudo da interação do gene Nramp1 com os loci da inflamação, sublinhagens homozigotas para os alelos R e S deste gene foram produzidas, AIRmaxRR, AIRmaxSS, AIRminRR e AIRminSS. Os animais AIRmaxRR foram sensíveis ao LPS, enquanto que os AIRminSS foram os mais resistentes a endotoxina. Quando desafiados com LPS, os animais AIRmaxRR apresentaram maior nível sérico de citocinas inflamatórias e maior expressão gênica de Tnf, Il6 e Il1b em células de fígado e medula óssea. Os AIRminRR expressaram e produziram maiores níveis de Il10. Através da análise da expressão gênica global em células de medula óssea, os AIRminSS mostraram um número maior de genes envolvidos na resposta ao LPS. / Lines of mice genetically selected for maximal (AIRmax) and minimal (AIRmin) acute inflammatory reaction differ in susceptibility to infection with Salmonella enterica serotype Typhimurium (S. Typhimurium) and to LPS sensitivity. Different frequencies of Nramp1 alleles, involved in innate resistance to S. Typhimurium infection, were found in AIRmax and AIRmin mouse lines. To study the Nramp1 gene interaction with acute inflammatory QTL, AIRmaxRR, AIRmaxSS, AIRminRR and AIRminSS sublines were produced. AIRmaxRR were found to be extremely sensitive to LPS, while the AIRminSS were the most resistant line to endotoxin. After LPS challenged, AIRmaxRR animals showed higher levels of inflammatory cytokine sera and as well as Tnf, Il6 and IL1b gene expression intensities in liver and bone marrow cells. Il10 expression was higher in AIRminRR mice. The global gene expression analysis in bone marrow cells after LPS stimulus showed higher number of differently expressed genes in AIRminSS mice.

Nosso objetivo foi determinar que tipo de estatina pode atenuar a lesão pulmonar aguda (LPA) induzida por lipopolissacarídeo (LPS) em camundongos da linhagem C57Bl/6. Trinta camundongos machos ( 23 g) foram divididos em 5 grupos (n=6 cada): grupo LPS (10 mg/kg) administrado intraperitonealmente (i.p.), LPS mais atorvastatina (10 mg/kg/dia; grupo LPS+A), LPS mais pravastatina (5 mg/kg/dia; grupo LPS+P) e LPS mais sinvastatina (20 mg/kg/dia; grupo LPS+S). O grupo controle recebeu salina i.p.. Em um grupo separado de camundongos (n=5), a soma das pressões pulmonares resistivas e viscoelásticas (DeltaPtot) e elastância estática (E[st]) foram medidas. Um dia após a administração de LPS os camundongos foram sacrificados (24 h) por deslocamento cervical e logo em seguida foi realizado lavado broncoalveolar (LBA). Os pulmões foram removidos para análise histopatológica e homogeneizados para análises bioquímicas (ELISA, catalase, superóxido dismutase, mieloperoxidase, substâncias reativas ao ácido tiobarbitúrico, carbonilação de proteínas e método de Griess). A quantidade de leucócitos foi menor no grupo LPS+P (p<0,01) e LPS+S (p<0,05) em comparação ao grupo LPS. Os níveis de MCP-1 e IL-6 reduziram no grupo LPS+P (p<0,01), enquanto o grupo LPS + S mostrou redução apenas nos níveis de IL-6 (p<0,05) em comparação ao grupo LPS. Marcadores redox (superóxido dismutase e catalase) foram menores no grupo LPS+A (p<0,01) em comparação ao grupo LPS. A peroxidação lipídica (malondialdeído e hidroperóxidos) diminuiu em todos os grupos tratados (p<0,05) quando comparados ao grupo LPS. A mieloperoxidase foi menor no grupo LPS+P (p<0,01) quando comparado ao grupo LPS. DeltaPtot e E(st) foram, significativamente, maiores no grupo LPS do que nos outros grupos. Nossos resultados sugerem que atorvastatina e pravastatina, mas não a sinvastatina, exibiram ações anti-inflamatórias e antioxidantes na LPA induzida por LPS. / To determinate what statins could attenuate acute lung injury (ALI) induced by lipopolysaccharide (LPS) in C57BL/6 mice. Young male mice ( 23 g) were divided into 5 groups (n=6 each): injected with LPS i.p. (10 mg/kg), LPS plus atorvastatin (10 mg/kg/day; LPS+A group) or pravastatin (5 mg/kg/day; LPS+P group) or simvastatin (20 mg/kg/day; LPS+S group). Control group received saline (i.p.). In a separated group of mice (n=5) the sum of pulmonary resistive and viscoelastic pressures (DeltaPtot) and static elastance (E[st]) were measured. One day later (24 h), the animals were sacrificed, BAL performed and lungs were removed for histopathological analysis and homogenized for biochemical analyses (ELISA, catalase, superoxide dismutase, myeloperoxidase, thiobarbituric acid reactive substances, protein carbonyls and griess assay). The amount of leukocytes was lower in LPS+P (p<0.01) and LPS+S (p<0.05). Cytokine levels of MCP-1 was lower in LPS+P (p<0.01) while IL-6 was lower in LPS+P (p<0.01) and LPS+S (p <0.05). Redox markers (superoxide dismutase and catalase) were lower in LPS+A (p<0.01). Lipid peroxidation (malondialdehyde and hydroperoxides) were lower in all treated groups (p<0.05). Myeloperoxidase was lower in LPS+P (p<0.01). DeltaPtot and E(st) were significantly higher in the LPS group than in the other groups. Our results suggest that atorvastatin and pravastatin, but no simvastatin, exhibits anti-inflammatory and antioxidant actions in LPS-induced ALI.

Post-operative ileus (POI) is the functional inhibition of propulsive intestinal motility which is a frequent occurrence following abdominal surgery in the horse and in humans. Rodent and human-derived data have shown that manipulation-induced activation of the resident muscularis externa (ME) macrophages in the intestine contributes to the pathophysiology of the disease. Most studies of the disease, specifically in the horse, have focussed on identification of risk factors, descriptive studies of the disease or the assessment of the efficacy of various therapeutic and prophylactic interventions. As a result, the proposed pathogenesis of equine POI is largely reliant on the translation of data from rodent models. The aims of this thesis were to identify macrophage populations in the normal equine gastrointestinal tract (GIT) and to study equine macrophage activation by stimulating equine bone marrow-derived macrophages (eqBMDMs) with lipopolysaccharide (LPS) as a model for intestinal macrophage activation. Firstly, the normal population of macrophages in the equine GIT was determined. Using CD163 as an immunohistochemical marker for macrophages. CD163+ve cells were present in all tissue layers of the equine intestine: mucosa, submucosa, ME and serosa. CD163+ve cells were regularly distributed within the ME, with accumulations adjacent to the myenteric plexus, and therefore to intestinal motility effector cells such as neurons and the Interstitial Cells of Cajal. The differentiation and survival of intestinal macrophages depends upon signals from the macrophage colony-stimulating factor (CSF-1) receptor. LPS translocation from the gut lumen is thought to be a key activator of ME macrophages. To provide a model for gut macrophages, a protocol was optimised to produce pure populations of equine bone marrow-derived macrophages (eqBMDMs) by cultivation of equine bone marrow in CSF-1. Macrophage functionality was assessed using microscopy, flow cytometry and phagocytosis assays. EqBMDMs responded to LPS stimulation with increases in expression of positive control genes, tumour necrosis factor alpha (TNF-α) and Indoleamine 2,3-dioxygenase (IDO1). The same mRNA was subjected to transcriptomic (RNA-Seq) analysis. Differential gene expression and network cluster analysis demonstrated an inflammatory response characterised by the production of pro-inflammatory cytokines such as interleukin 1 beta (IL-1β) and interleukin 6 (IL-6). However, in contrast to rodent macrophages, eqBMDMs failed to produce nitric oxide in response to LPS, showing species-specific variation in innate immune biology. Using these data, we compared gene expression in normal equine intestine and in intestine from horses undergoing abdominal surgery for colic (abdominal pain). Horses undergoing abdominal surgery showed evidence of increased expression of IL-1β, IL-6 and TNF-α in the mucosa and ME when compared to control tissue. Horses with post-operative reflux (POR), a clinical sign of POI, had increased gene expression of IL-1β, IL-6 and TNF-α compared to horses that did not develop POR following abdominal surgery. These preliminary data suggest that there is macrophage activation within the ME of the intestine during abdominal surgery in the horse, and that a greater activation state is present in horses that subsequently develop POR. The final part of this study was to investigate the effect of a long-acting form of CSF- 1, an Fc fusion protein (CSF1-Fc), as a potential treatment for POI using a mouse model. This work, performed in collaboration with another research group, found that mice lacking the C-C chemokine receptor type 2 (CCR2) gene, which is required for monocyte recruitment into tissues, had a longer recovery period following intestinal manipulation (IM) than wild type (WT) mice. With the administration of CSF1-Fc, infiltration of neutrophils to the ME was reduced and the number of macrophages in the ME was increased in both WT and CCR2-/- mice following IM. Administration of CSF1-Fc in CCR2-/- mice improved recovery of gastrointestinal transit three days following IM, to the same extent as WT mice. Network cluster analysis and RT-qPCR of the ME revealed clusters of genes induced and downregulated by CSF1-Fc, with increased expression of anti-inflammatory and pro-resolving genes after IM in WT and CCR2-/- mice following treatment with CSF1-Fc.

Os efeitos causados pelo tratamento em conjunto da insulina e do colecalciferol em indivíduos diabéticos não estão completamente elucidados. O presente trabalho avaliou o efeito de ambos os hormônios nos rins, no fígado, no coração e nos parâmetros hematológicos de camundongos machos (C57BL/6) sadios e diabéticos, bem como a ação do colecalciferol (in vitro) na resposta imunológica desenvolvida pelas células RAW 264.7 e pelos macrófagos peritoneais (MP) após estímulo com lipopolissacarídeo (LPS). Após dez dias da administração da aloxana (60 mg/kg), animais diabéticos exibiram redução do ganho de peso corporal e hiperglicemia quando comparados aos animais que receberam salina. No sétimo dia do período experimental, foi verificado que animais diabéticos que não receberam nenhum hormônio, em relação aos não diabéticos, exibiram redução do peso corporal, dos níveis de hemoglobina (Hb), hematócrito, hematimetria, insulina, TNF-&#945; e IL-6 (coração) e aumento da glicemia, da relação peso corpóreo/peso rim esquerdo, das concentrações séricas de ureia, creatinina, Fosfatase Alcalina (FAL), Lactato desidrogenase (LDH) e lactato, fator de necrose tumoral (TNF)-&#945;, interleucina (IL)-6 e IL-10 (no rim); o tratamento com insulina (1 UI/300 mg/dL glicemia), em relação aos animais diabéticos não tratados, promoveu aumento do peso corporal, das concentrações séricas de insulina e redução da glicemia, das concentrações séricas de ureia e da razão TNF-&#945;/IL-10 (coração); o tratamento com colecalciferol (800 UI/dia), em relação aos animais diabéticos não tratados, promoveu aumento das concentrações séricas de 25-hidroxicolecalciferol [25(OH)D], Hb, hematócrito, hematimetria, IL-10 (coração) e reduziu IL-6, IL-10, TNF-&#945; e EPO (rim); os animais diabéticos tratados com insulina, em relação aos animais diabéticos suplementados com colecalciferol apresentaram aumento do peso corpóreo, de ureia sérica, IL-6 e TNF-&#945; (coração) e redução da glicemia, das concentrações séricas de lactato, de IL-6, TNF-&#945;, IL-10 e EPO (rim); os animais -que receberam ambos os hormônios, em relação aos animais tratados com insulina, apresentaram aumento sérico de insulina e lactato; os animais diabéticos que receberam ambos os hormônios, em relação aos animais diabéticos tratados com colecalciferol, exibiram aumento sérico de 25(OH)D, de insulina, além da redução das concentrações de IL-10, da razão de TNF-&#945;/IL-10 e TNF-&#945;/IL-6 (coração); animais diabéticos que receberam ambos os hormônios, em relação aos diabéticos não suplementados com colecalciferol, exibiram: aumento de insulina sérica e redução das concentrações séricas de ureia e das razões renal e hepática de TNF-&#945;/IL-6; células RAW 264.7 estimuladas pelo LPS e tratadas com 100 nM colecalciferol exibiram maior expressão da CYP27B1 e redução na liberação de mediadores inflamatórios quando comparadas ao grupo estimulado pelo LPS. Entretanto, não foi observado o mesmo efeito nos MP. Em conjunto, os resultados sugerem que: 1) em animais diabéticos, o colecalciferol pode modular parâmetros hematológicos e que a insulina pode melhorar a função renal, bem como a recuperação do peso corporal; 2) o colecalciferol pode ser metabolizado pelas células RAW 264.7 e modular a resposta imunológica desencadeada pelo LPS. / The effects caused by the treatment of insulin and cholecalciferol in diabetic subjects are not completely elucidated. The present study evaluated the effect of both hormones on the kidneys, liver, heart and hematological parameters of healthy and diabetic male mice (C57BL/6), as well as the action of cholecalciferol (in vitro) on the immune response developed by the cells RAW 264.7 and peritoneal macrophages (MP) after stimulation with lipopolysaccharide (LPS). After ten days of alloxan administration (60 mg/kg), diabetic animals exhibited a reduction in body weight gain and hyperglycemia when compared to animals that received saline. On the seventh day of the experimental period, it was verified that diabetic animals that did not receive any hormones, in relation to non-diabetics, showed reduction of body weight, hemoglobin (Hb), hematocrit, hematimetry, insulin, TNF-&#945; and IL- 6 (heart) and increased glycemia, body weight / left kidney weight, serum urea, creatinine, Phosphatase Alkaline, lactate dehydrogenase (LDH) and lactate levels, tumor necrosis factor (TNF) interleukin (IL) -6 and IL-10 (in the kidney); diabetic mice treated with insulin (1 IU / 300 mg/dL glycemia) in relation to untreated diabetic animals promoted increased body weight, serum insulin levels and blood glucose lowering, serum urea levels and TNF-&#945; ratio / IL-10 (heart); diabetic animals treated with cholecalciferol (800 IU/day), in relation to untreated diabetic animals, exhibited increased serum levels of 25-hydroxycholecalciferol [25 (OH) D], Hb, hematocrit, hematimetry, IL-10 (heart) and reduced IL-6, IL-10, TNF-&#945; and EPO (kidney);insulin-treated diabetic animals compared to diabetic animals supplemented with cholecalciferol exhibited an increase of body weight, serum urea, IL-6 and TNF-&#945; (heart) and a reduction of glycaemia, serum lactate levels, IL-6, TNF- &#945;, IL-10 and EPO (kidney); animals that received both hormones, compared to animals treated with insulin exhibited an increase of insulin and lactate serum levels; diabetic animals that received both hormones, compared to diabetic animals treated with cholecalciferol, exhibited an increase of 25(OH)D and insulin serum levels, and a reduction of IL-10, TNF-&#945;/IL-10 and TNF-&#945;/IL-6 ratios (heart); diabetic animals that received both hormones, compared to diabetic animals not supplemented with cholecalciferol, exhibited an increase of insulin and reduced urea serum levels and reduced renal and hepatic TNF-&#945;/IL-6 ratios; LPS-stimulated RAW 264.7 cells and treated with 100 nM cholecalciferol exhibited greater CYP27B1 expression and reduced release of inflammatory mediators when compared to the LPS-stimulated group. However, the same effect was not observed in PM. Taken together, the results suggest that: 1) in diabetic animals, cholecalciferol may modulate hematological parameters and that insulin may improve renal function as well as recovery of body weight; 2) cholecalciferol can be metabolized by RAW 264.7 cells and modulate the immune response triggered by LPS.

Milk fat globule membrane surrounds the fat droplets of milk. It is a biopolymer containing primarily membrane glycoproteins and polar lipids which contribute to its properties as a possible neutraceutical. The aims of the studies were to determine if dietary milk fat globule membrane: (1) confers protection against colon carcinogenesis; and (2) promotes gut mucosal integrity while decreasing inflammation compared to diets containing corn oil or anhydrous milk fat. Aim 1. Three dietary treatments differing only in the fat source were formulated: (1) AIN-76A, corn oil; (2) AIN-76A, anhydrous milk fat; and (3) AIN-76A, 50% milk fat globule membrane, 50% anhydrous milk fat. Each diet was formulated to contain 50 g/kg diet of fat and to be identical in macro and micro nutrient content. To assess protection against colon carcinogenesis, male, weanling Fischer-344 rats were randomly assigned to one of the three dietary treatments. Animals were injected with 1,2-dimethylhydrazine once per week at weeks 3 and 4. After 13 weeks animals were sacrificed, colons were removed, and aberrant crypt foci were counted by microscopy. Rats fed the milk fat globule membrane diet (n = 16) had significantly fewer aberrant crypt foci (20.9 ± 5.7) compared to rats fed corn oil (n = 17) or anhydrous milk fat (n = 16) diets (31.3 ± 9.5 and 29.8 ± 11.4 respectively; P < 0.05). Aim 2. Male BALB/c mice were randomly assigned to one of two diets: AIN- 76A, corn oil or AIN-76A, 50% milk fat globule membrane, 50% anhydrous milk fat. After 5 weeks mice were injected with saline vehicle control or lipopolysaccharide and gavaged with dextran-FITC. To assess gut mucosal integrity and inflammation, serum samples were assayed for dextran-FITC 24 and 48 hours after gavage, and a panel of 16 cytokine concentrations was analyzed. Serum concentrations of IL-6, IL-10, IL-17, MCP-1, IFNγ, and TNFα decreased and gut permeability decreased 45% in lipopolysaccharide challenged mice fed milk fat globule membrane diet compared to control diet at 24 hours (P < 0.05). Overall, the results of these aims suggest that diets containing milk fat globule membrane are protective against colon carcinogenesis, inhibit the inflammatory response, and protect against gastrointestinal stress.